HomeInsightsPE

Lupin Ltd PE Ratio

Lupin Ltd PE Ratio

stocks purchased

₹ 3.7 Cr

Volume transacted

stocks purchased

16.7 K

stocks traded

Last Updated time: 04 Oct 15:30 PM

Image

Lupin Ltd

NSE: LUPIN

PE

44

Last updated: 04 Oct 15:30 PM

Key Highlights

  • The P/E Ratio of Lupin Ltd is 44 as of 04 Oct 15:30 PM.
  • The P/E Ratio of Lupin Ltd changed from 55.2 on March 2019 to 38.5 on March 2024 . This represents a CAGR of -5.83% over 6 years. .
  • The Latest Trading Price of Lupin Ltd is ₹ 2197 as of 04 Oct 16:01.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 21.8. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Lupin Ltd

No data available

Company Fundamentals for Lupin Ltd

No data available

Image

Lupin Ltd

NSE: LUPIN

PRICE

2197.6

14.10 (0.65%)

stock direction

Last updated: 04 Oct 16:01

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
03 Oct 20242183.5
01 Oct 20242194.25
30 Sep 20242190.2
27 Sep 20242221.5
26 Sep 20242187.45
25 Sep 20242218.65
24 Sep 20242214.3
23 Sep 20242181.85
20 Sep 20242152.15
19 Sep 20242170.2

SWOT Analysis Of Lupin Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Lupin Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Lupin Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Lupin Ltd4499,598
Sun Pharmaceuticals Industries Ltd434,59,137
Divis Laboratories Ltd861,44,115
Cipla Ltd301,33,733
Torrent Pharmaceuticals Ltd681,14,735
Dr Reddys Laboratories Ltd201,12,387

Key Valuation Metric of Lupin Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Lupin Ltd

No data available

* All values are in crore

Historical Revenue of Lupin Ltd

No data available

* All values are in crore

Historical EBITDA of Lupin Ltd

No data available

* All values are in crore

Historical Net Profit of Lupin Ltd

No data available

* All values are in crore

Historical Dividend Payout of Lupin Ltd

No data available

* All values are in %

About Lupin Ltd

  • Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.
  • The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.
  • Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar.
  • In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd.

Lupin Ltd News Hub

News

Lupin's Pithampur Unit-1 API and finished product facility concludes USFDA inspection

Lupin informed that the U.S. FDA inspected Lupin's Pithampur Unit-1 API and finished produ...

Read more

28 Sep 202410:40

News

Lupin's Pithampur facility completes USFDA inspection with 3 observations

The inspection concluded with 3 observations on both the API and Finished Product sides. T...

Read more

28 Sep 202414:54

News

Lupin allots 5,893 equity shares under ESOP

Lupin has allotted 5,893 equity shares under ESOP on 20 September 2024. Post allotment, th...

Read more

20 Sep 202412:42

News

Lupin enters into patent license agreement with Takeda

Lupin announced that it has entered into a non-exclusive patent license agreement with Tak...

Read more

18 Sep 202413:43

News

Lupin joins hand with Takeda to Launch Vonoprazan Tablets in India

Vonoprazan is a novel potassium-competitive acid blocker (P-CAB). Unlike traditional acid ...

Read more

18 Sep 202414:50

News

Lupin gains on inking pact to acquire 43% stake in Sunsure Solarpark

Sunsure Solarpark, a subsidiary of Sunsure Energy, is a renewable energy company focused o...

Read more

12 Sep 202412:26

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Lupin Ltd

What is the current PE Ratio of Lupin Ltd?

The Current PE Ratio of Lupin Ltd is 44.0 as on 4 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 4 Oct 2024.

What was the PE Ratio of Lupin Ltd last year?

The PE Ratio of Lupin Ltd was 68.56 last year, now the PE ratio is 44.0, showing a year-on-year growth of -35.8%.

What does the PE Ratio of Lupin Ltd indicate about its stock?

The PE Ratio of Lupin Ltd is 44.0. This ratio indicates that investors are willing to pay 44.0 times the earnings per share for each share of Lupin Ltd.

What is the PE Ratio Growth of Lupin Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Lupin Ltd grew by -35.8% whereas, the EPS ratio grew by 122.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*